Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

March 7, 2025

Study Completion Date

March 7, 2025

Conditions
Knee OsteoarthritisKnee Pain ChronicKnee Arthritis
Interventions
BIOLOGICAL

TTAX03

Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord

BIOLOGICAL

Saline

2 mL Sterile, preservative free 0.9% NaCl

Trial Locations (10)

19063

Rothman Orthopaedic Institute, Media

30327

Paragon Sports Medicine, Atlanta

33351

Precision Clinical Research, Sunrise

34232

Gulfcoast Research Institute, Sarasota

35205

UAB Orthopaedic Surgery, Birmingham

35243

Alabama Orthopaedic Center, Birmingham

43201

Manage Sites/The Ohio State University Wexner Medical Center, Sports Medicine The Ohio State University Wexner Medical Center, Sports Medicine, Columbus

70121

Ochsner Health Center, Jefferson

85712

Tuscon Orthopedic Institute, Tucson

91942

Horizon Clinical Research, La Mesa

All Listed Sponsors
lead

BioTissue Holdings, Inc

INDUSTRY

NCT05079035 - Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA | Biotech Hunter | Biotech Hunter